Biogen expects Leqembi and new rare disease and depression treatments to help offset revenue lost from multiple sclerosis ...

Determining the various costs of Medicare can be confusing. There are annual deductibles, monthly premiums and doctor visit ...

If you enrolled in an optional Medicare Part D plan in 2024 or before, at some point you probably faced a coverage gap called the “donut hole,” a temporary limit on what your Part D plan will pay for ...

Novartis' strong drug pipeline and financials support an 11% annual return by 2027. Learn why NVS stock offers 33% return ...

The Trump administration is firing thousands of federal workers on probationary status, or those without civil service ...

It caps off the first full quarter with David Joyner, a longtime CVS executive, as CEO of the troubled retail drugstore chain ...

A bill that would subject pharmacy benefit managers to licensing by the state Department of Insurance faces a hurdle: Gov.

West Pharma’s financial strength is solid, and the firm has historically managed a very strong balance sheet. As of year-end 2023, West had total debt outstanding of $206 million. West has ...

Colorado’s spending on highly effective but costly weight-loss drugs for state workers more than quadrupled from 2023 to 2024 ...

Aptar has a narrow economic moat, with durable switching costs in the Pharma business supported by intangible assets throughout the product portfolio from expertise in product regulation, design, and ...

CVS Health steered through rising costs in its insurance division to handily beat profit expectations on Wall Street. Removing one time costs and benefits, earnings were $1.19 per share, easily ...